Financial Year |
March 31 2023 |
Monetary Funds |
394,073,722.12 |
Held-for-trading Financial Assets |
190,094,375.89 |
Notes Receivable |
-- |
Accounts Receivable |
187,965,352.87 |
Advances to Suppliers |
1,535,135.07 |
Other Receivables |
25,599,921.46 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
48,971,536.76 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
25,451.66 |
Total Current Assets |
848,265,495.83 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
26,814,488.19 |
Investment Properties |
34,415,183.48 |
Fixed Assetes |
47,984,742.22 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
29,356,934.83 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
11,234,130.86 |
Other Non-Current Assets |
33,381,994.45 |
Sub-Total of Non-Current Assets |
186,918,665.79 |
Total Assets |
1,035,184,161.62 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
160,426,659.95 |
Accounts Received In Advance |
481,889.78 |
Employee Compensation Payable |
4,523,507.76 |
Taxes Payable |
12,850,035.20 |
Interest Payable |
-- |
Dividend Payable |
16,950,046.40 |
Other payables |
55,717,594.82 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
993,886.35 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
238,812,346.93 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
746,455.84 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
8,831,005.04 |
Total Liabilities |
247,643,351.97 |
Paid-In Capital(Or Share Stock) |
211,875,580.00 |
Capital Surplus |
335,770,845.00 |
Surplus Reserve |
32,451,084.38 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
192,048,960.99 |
Minority Stockholder's Interest |
15,394,339.28 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
772,146,470.37 |
Owner's Equity(Stockholder's Equity) |
787,540,809.65 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,035,184,161.62 |